The purpose of this legislation, known as the "Old Drugs, New Cures Act," is to encourage the development of new uses for older medications by changing how these drugs are treated under Medicare and Medicaid. The main goal is to ensure that certain research drugs are not classified as simple extensions of existing drugs, which would affect the financial rebates that manufacturers owe to these programs.